ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

GLYC GlycoMimetics Inc

1.8399
0.1199 (6.97%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
GlycoMimetics Inc GLYC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.1199 6.97% 1.8399 13:00:05
始値 安値 高値 終値 前日終値
1.67 1.63 1.84 1.83 1.72
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
2024/3/2720:00BWGlycoMimetics Reports Highlights and Financial Results for..
2024/3/1320:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
2024/3/0123:16EDGAR2Form 8-K - Current report
2024/2/2621:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
2024/2/1221:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
2024/1/1806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0421:00BWGlycoMimetics Announces Positive Initial Safety and..
2024/1/0321:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
2024/1/0306:30EDGAR2Form 8-K - Current report
2024/1/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1102:00BWGlycoMimetics Announces Independent Presentations on..
2023/11/0921:00BWGlycoMimetics to Participate in Upcoming Jefferies London..
2023/11/0321:35EDGAR2Form 8-K - Current report
2023/11/0321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0320:00BWGlycoMimetics Reports Highlights and Financial Results for..
2023/10/2321:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
2023/10/2020:00BWGlycoMimetics to Report Third Quarter 2023 Financial Results..
2023/10/0405:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2605:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0620:00BWGlycoMimetics Announces First Cohort Dosed in Human Phase 1a..
2023/9/0520:00BWGlycoMimetics to Participate in Upcoming H.C. Wainwright..
2023/8/1720:00BWGlycoMimetics Reports Inducement Grant Under Nasdaq Listing..
2023/8/0221:35EDGAR2Form 8-K - Current report
2023/8/0221:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0220:00BWGlycoMimetics Reports Highlights and Financial Results for..
2023/7/1920:00BWGlycoMimetics to Report Second Quarter 2023 Financial..
2023/6/2621:00BWGlycoMimetics Announces Its Addition to the Russell..
2023/6/1521:00BWGlycoMimetics Announces U.S. Food and Drug Administration..
2023/5/3120:00BWGlycoMimetics to Participate in Upcoming Jefferies 2023..

最近閲覧した銘柄

Delayed Upgrade Clock